Kaligia Biosciences completes calibration testing for the latest RBA device
Kaligia Biosciences’ Reagent-Free Whole Blood Hemoglobin Analyzer has been tested in conjunction with our collaborators at AdventHealth & HEP.
We are currently in the submission process with the FDA for 510(k) approval.
On the forefront of healthcare technology
Revolutionary high-speed point of care devices.
Our Basic Process
Quantifiable Results, Unprecedented Speed.
Kaligia Biosciences is tapping into the power of emerging technologies and creative problem-solving to innovate a new breed of biosensors. These devices, which produce quantifiable results with unprecedented speed and accuracy, align with Kaligia Biosciences’ mission to redefine medical diagnosis and transform healthcare delivery from reactive to proactive.
Solving Complex Problems Together
Kaligia Biosciences has begun clinical trials in partnership with numerous hospitals in the Tampa Bay area.